Annexes I, IV and VI to Implementing Regulation (EU) 2020/2002 are amended as follows:
Annex I is amended as follows:
in point 1, the entry for ‘Infection with epizootic haemorrhagic disease virus’ is deleted;
in point 4, the entry for ‘Infection with bluetongue virus (serotypes 1-24) (“infection with BTV”) by serotype’ is deleted;
the following point 6 is added:
‘6. Listed diseases of terrestrial animals subject to Union notification in accordance with Article 3(1), point (d), and Article 3(2), point (d)
Infection with bluetongue virus (serotypes 1-24) (“infection with BTV”) by serotype
Infection with epizootic haemorrhagic disease virus’;
Annex IV is amended as follows:
the entry for Czechia is replaced by the following:
Member State: | Notification and reporting regions:
‘Czechia | kraj’
the entry for Denmark is replaced by the following:
Member State: | Notification and reporting regions:
‘Denmark | municipality’
the entry for Germany is replaced by the following:
Member State: | Notification and reporting regions:
‘Germany | Kreis’
the entry for Hungary is replaced by the following:
Member State: | Notification and reporting regions:
‘Hungary | vármegye’
the entry for the Netherlands is replaced by the following:
Member State: | Notification and reporting regions:
‘the Netherlands | provincie’
the entry for Austria is replaced by the following:
Member State: | Notification and reporting regions:
‘Austria | Bundesland’
in Annex VI, Section 5 is replaced by the following:
Information to be included by the competent authority in applications for the recognition of a disease-free status for Member State, or a zone or compartment thereof, if more than one zone or compartment are included in the territorial scope of the application, where the disease has been reported in the previous 25 years, and it has been eradicated from the territory concerned:
Disease-free status from infection with Brucella abortus, B. melitensis and B. suis as regards kept bovine animals:
the information referred to in point 1 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from infection with Brucella abortus, B. melitensis and B. suis with or without vaccination at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (a), of Delegated Regulation (EU) 2020/689.
Disease-free status from infection with Brucella abortus, B. melitensis and B. suis as regards kept ovine and caprine animals:
the information referred to in point 2 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from infection with Brucella abortus, B. melitensis and B. Suis with or without vaccination at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (a), of Delegated Regulation (EU) 2020/689.
Disease-free status from infection with MTBC:
the information referred to in point 3 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from infection with MTBC at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (b), of Delegated Regulation (EU) 2020/689.
Disease-free status from EBL:
the information referred to in point 4 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from EBL at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (c), of Delegated Regulation (EU) 2020/689.
Disease-free status from IBR/IPV:
the information referred to in point 5 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from IBR/IPV at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (d), of Delegated Regulation (EU) 2020/689.
Disease-free status from infection with ADV:
the information referred to in point 6 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from infection with ADV at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (e), of Delegated Regulation (EU) 2020/689.
Disease-free status from BVD:
the information referred to in point 7 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from BVD at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (f), of Delegated Regulation (EU) 2020/689.
Disease-free status from infection with RABV:
the information referred to in point 8 of Section 6 of Annex VI;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (g), of Delegated Regulation (EU) 2020/689.
Disease-free status from category B and C diseases of aquatic animals:
the information referred to in point 10 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from category B and C diseases of aquatic animals at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, points (k) to (q), of Delegated Regulation (EU) 2020/689.
Information on documented evidence on compliance with the requirements set out in points (a) to (f) of Section 1 of Part III of Annex V to Delegated Regulation (EU) 2020/689 shall be included in applications for the recognition of disease-free status for infestation with Varroa spp., where the disease either has never been reported, or it has been eradicated and not reported for at least 25 years, prior to the date of application for the recognition of disease-free status.
Information on documented evidence on compliance the requirements set out in points (a) to (e) of Section 1 of Part IV of Annex V to Delegated Regulation (EU) 2020/689 shall be included in applications for the recognition of disease-free status from infection with Newcastle disease virus infection without vaccination.’